Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer
NCT02985203
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
45
Enrollment
OTHER
Sponsor class
Stopped
No participants were enrolled as schedule.
Conditions
Lung Neoplasm Malignant
Interventions
DRUG:
Vinorelbine Oral
Sponsor
Guangdong Association of Clinical Trials